Brian Wilson has been covering biotech stocks for two years, and has been published extensively in the online investment community. He founded Bio-Wire in 2012 to provide a more streamlined content platform for biotech investors, and continues to provide high-level content. Prior to this, Wilson worked in the life sciences industry and attended Vanderbilt University.
"NBS is on track for its phase 2, AMR-001 data release in 2014."
Brian Wilson, Seeking Alpha
"MSLP has a prominent brand, and operates in a niche market that has been built largely on brand association."
The Life Sciences Report Interview with Brian Wilson